Skip to content

RapidFor™

by Vitrosens Biotechnology Inc. Türkiye EUDAMED

Ref VMPO01, VMPO01EDModel VMPO01EP EMDN W0102160903

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR NumberB-08683548250124 Basic UDI-DIDate7 Sep 2026RegisteredStatusActive
European UnionCE/IVDD NumberB-08683548250124 Basic UDI-DIDate7 Sep 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDR, CE/IVDD Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Tsh (Fia)
Model / Reference
VMPO01EP, VMPO01, VMPO01ED
Primary DI / UDI-DI
08683548250124, 08684595035269
Basic UDI-DI
B-08683548250124, 868354825VMPO01EPMZ, B-08684595035269
EMDN Code
W0102160903 Thyroid-stimulating hormone - rt & poc
Device Class
Class IVD General
Class B
Market of Registration
Türkiye

Manufacturer details

EUDAMED SRN
TR-MF-000026452

Other devices from Vitrosens Biotechnology Inc.

See all devices from Vitrosens Biotechnology Inc. →

Properties & raw data

Show properties, registry sources and raw records
  • Reagent
  • Professional Testing
Other properties (9)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (4)

  • EUDAMED ba4dae88-551a-4635-ad91-000f83eadc13 61 fields · synced 22 Oct 2026
  • EUDAMED 08684595035269|868354825VMPO01EPMZ 61 fields · synced 23 Oct 2026
  • EUDAMED 08683548250124|868354825VMPO01EPMZ 61 fields · synced 24 Oct 2026
  • EUDAMED 08684595035269|B-08684595035269 61 fields · synced 24 Oct 2026